Physician profile
Christopher E Stevens
NPI 1093712291
$752.67
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.37 · 2021: $83.29 · 2022: $344 · 2023: $45.12 · 2024: $116 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $356.51 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $113.32 | 2020-2025 | Dupixent |
| Abbvie INC. | $103.84 | 2020-2022 | |
| Optinose US, INC. | $62.61 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.33 | 2021-2022 | |
| Inspire Medical Systems, INC. | $21.65 | 2025 | Inspire |
| Smith+Nephew, INC. | $18.45 | 2025 | |
| Acclarent, INC | $16.03 | 2023 | Trudi Nav Cable |
| Kowa Pharmaceuticals America, INC. | $12.69 | 2022 | |
| Trevena, INC. | $11.77 | 2021 | |
| Xoran Technologies LLC | $10.47 | 2023 | Minicat |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.